Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Taiwan
Clinical trial register · Taiwan

Clinical Trials in Taiwan

Every study on the ClinicalTrials.gov registry that lists a site in Taiwan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2860 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:18 UTC
2860
Studies in scope
all four open statuses
1565
Recruiting now
open to new participants
340
Lead sponsors
across recruiting studies
Top sites
Taipei 158 Taichung 139 Tainan 117 Kaohsiung City 115 Taoyuan 102
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
National Taiwan University Hospital428 AstraZeneca166 Chang Gung Memorial Hospital152 Merck Sharp & Dohme LLC89 China Medical University Hospital75 Novartis Pharmaceuticals69 AbbVie67 Janssen Research & Development, LLC63 Hoffmann-La Roche60 Eli Lilly and Company59 Pfizer54 National Cheng-Kung University Hospital47 Taipei Veterans General Hospital, Taiwan44 National Yang Ming Chiao Tung University41 Taichung Veterans General Hospital39 Taipei Medical University38 Sanofi37 Amgen35 Kaohsiung Medical University Chung-Ho Memorial Hospital33 Bristol-Myers Squibb32 National Health Research Institutes, Taiwan32 Daiichi Sankyo28 Boehringer Ingelheim24 Gilead Sciences24 GlaxoSmithKline23 Show all 501 Clear sponsor filter
Site location
Taipei158 Taichung139 Tainan117 Kaohsiung City115 Taoyuan102 New Taipei City38 Changhua33 Hsinchu16 Taoyuan City15 Yung Kang City9 Hualien City8 Yunlin7 Chiayi City5 Tainan County5 Zhubei4 Liuying3 Yilan2 Liou Ying Township2 Kweishan1 Lukang Township1 Keelung1 Niaosong1 Changhua County1 Kaohsiung Hsien1 Putzu City1 Show all 26
All 26 locations
Target enrolment
to

Trials in this register

166 of 2860 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Taiwan
Start
Recruiting
AstraZeneca
Phase 3
750
Taipei, Taoyuan
2026-09-24
Recruiting
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
NCT07816666Platinum-sensitive Relapsed Epithelial Ovarian Cancer, Platinum-sensitive Relapsed Fallopian Tube Cancer, Platinum-sensitive Relapsed Primary Peritoneal Cancer
DrugsTorvutatug samrotecan·Bevacizumab
AstraZeneca
Phase 3
600
Kaohsiung City, Taichung, Tainan, Taipei
2026-09-24
Recruiting
AstraZeneca
Phase 3
950
Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan
2026-09-16
Recruiting
AstraZeneca
Phase 3
1,330
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2026-09-15
Recruiting
AstraZeneca
Phase 3
2,800
Changhua, Hualien City, Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan
2026-09-01
Recruiting
AstraZeneca
Phase 3
1,072
Kaohsiung City, Taichung, Taipei
2026-08-31
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Kaohsiung City, New Taipei City, Taichung, Taipei, Taoyuan, Yilan
2026-08-24
Recruiting
AstraZeneca
Phase 3
7,000
Changhua, Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan, Yung Kang City
2026-08-21
Recruiting
AstraZeneca
Phase 3
1,500
Changhua, Kaohsiung City, Taichung, Tainan, Taipei, Zhubei
2026-08-20
Recruiting
AstraZeneca
Phase 3
2,500
Changhua, Chiayi City, Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan
2026-08-19
Recruiting
AstraZeneca
Phase 3
915
Kaohsiung City, Tainan, Taipei, Taoyuan
2026-07-16
Recruiting
AstraZeneca
Phase 3
1,200
Changhua, Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan, Yung Kang City
2026-07-06
Recruiting
AstraZeneca
Phase 3
2,000
Changhua, Kaohsiung City, New Taipei City, Taichung, Tainan, Tainan County, Taipei, Taoyuan
2026-07-06
Recruiting
AstraZeneca
Phase 3
900
Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan, Zhubei
2026-07-06
Recruiting
AstraZeneca
Phase 3
800
Changhua, Kaohsiung City, New Taipei City, Taichung, Tainan, Tainan County, Taipei
2026-07-06
Recruiting
AstraZeneca
Phase 3
4,500
Changhua, Kaohsiung City, Taichung, Tainan, Tainan County, Taipei
2026-06-29
Recruiting
AstraZeneca
Phase 3
750
Taipei, Taoyuan
2026-06-26
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Kaohsiung City, Taichung, Taipei, Taoyuan, Yunlin
2026-06-11
Recruiting
AstraZeneca
Phase 3
670
Kaohsiung City, Taipei, Taoyuan
2026-05-04
Recruiting
AstraZeneca
Phase 3
245
Kaohsiung City, New Taipei City, Taichung, Tainan, Tainan County, Taipei, Taoyuan, Zhubei
2026-04-13
Recruiting
AstraZeneca
Phase 1
40
Tainan, Taipei, Taoyuan
2026-03-31
Recruiting
AstraZeneca
Phase 3
508
Taipei
2026-02-23
Recruiting
AstraZeneca
Phase 3
2,130
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2026-02-03
Recruiting
AstraZeneca
Phase 3
1,100
Changhua, New Taipei City, Taichung, Tainan, Taipei, Taoyuan
2025-12-29
Recruiting
AstraZeneca
Observational
600
Taichung, Taoyuan City
2025-12-26
Recruiting
AstraZeneca
Observational
1,400
Yunlin, Taichung, Tainan, Taipei
2025-12-15
Active, closed
AstraZeneca
Phase 2
222
Kaohsiung City, New Taipei City, Taichung, Taipei, Taoyuan
2025-12-05
Recruiting
AstraZeneca
Phase 3
1,100
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2025-12-04
Recruiting
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
NCT07201558Rheumatoid Arthritis, Systemic Lupus Erythematosus
DrugSurovatamig
AstraZeneca
Phase 1
48
Kaohsiung City, Taichung, Taipei, Taoyuan
2025-12-02
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
NCT06996782Advanced or Metastatic Non-small Cell Lung Cancer
DrugsRamucirumab·Rilvegostomig·Nab-paclitaxel·Pemetrexed
AstraZeneca
Phase 1/2
152
Taichung, Taipei
2025-11-24
Recruiting
AstraZeneca
Phase 1/2
83
Taichung, Taipei
2025-11-12
Recruiting
AstraZeneca
Phase 2
435
Kaohsiung City, Taichung, Taipei, Taoyuan
2025-11-06
Recruiting
AstraZeneca
Phase 1
72
Kaohsiung City, Tainan, Taipei
2025-11-03
Recruiting
AstraZeneca
Phase 3
400
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2025-10-31
Recruiting
AstraZeneca
Phase 1/2
164
Taichung, Taipei
2025-09-24
Recruiting
AstraZeneca
Phase 2
278
Liuying, Taichung, Tainan, Taipei, Taoyuan
2025-08-07
Active, closed
AstraZeneca
Phase 3
212
Taichung, Taipei, Taoyuan, Zhubei
2025-08-07
Recruiting
AstraZeneca
Phase 3
700
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2025-08-06
Recruiting
AstraZeneca
Phase 3
800
New Taipei City, Taichung, Tainan, Taipei
2025-08-01
Recruiting
AstraZeneca
Phase 2
100
Kaohsiung City, Tainan, Taipei, Taoyuan
2025-07-17
Recruiting
AstraZeneca
Phase 2
987
Changhua, Kaohsiung City, Taichung, Taipei, Taoyuan, Yung Kang City
2025-06-27
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
DrugAZD0780
AstraZeneca
Phase 3
473
Kaohsiung City, Taichung, Taipei
2025-06-10
Recruiting
AstraZeneca
Phase 3
15,100
Changhua, Hsinchu, Hualien City, Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei
2025-06-04
Active, closed
AstraZeneca
Phase 3
3,103
Kaohsiung City, Taichung, Tainan, Taipei
2025-05-28
Recruiting
AstraZeneca
Phase 3
1,220
Changhua, Kaohsiung City, Taichung, Tainan, Tainan County, Taipei, Taoyuan
2025-05-06
Recruiting
AstraZeneca
Phase 3
600
Changhua, Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei
2025-03-27
Recruiting
AstraZeneca
Phase 1/2
304
Taipei, Taoyuan
2025-03-27
Recruiting
AstraZeneca
Phase 2
540
Kaohsiung City, New Taipei City, Taichung, Taipei
2025-03-26
Recruiting
AstraZeneca
Phase 3
11,300
Changhua, Hsinchu, Hualien City, Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei
2025-03-14
Active, closed
AstraZeneca
Phase 2
82
Kaohsiung City, Taipei, Taoyuan, Yung Kang City
2025-03-12
Recruiting
AstraZeneca
Phase 3
5,000
New Taipei City, Taichung, Taipei, Taoyuan, Yung Kang City
2025-03-03
Recruiting
AstraZeneca
Phase 3
840
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2025-03-01
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
NCT06564038Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma
DrugsSurovatamig·Acalabrutinib·Vincristine·Doxorubicin
AstraZeneca
Phase 1/2
408
Changhua, Kaohsiung City, Tainan, Taipei
2025-01-30
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)
DrugSurovatamig
AstraZeneca
Phase 2
270
Kaohsiung City, Taichung, Tainan, Taipei
2024-11-27
Recruiting
AstraZeneca
Phase 3
1,160
Kaohsiung City, New Taipei City, Taichung, Tainan, Taoyuan
2024-11-27
Recruiting
AstraZeneca
Phase 3
1,160
Kaohsiung City, New Taipei City, Taichung, Tainan, Taoyuan
2024-11-18
Recruiting
AstraZeneca
Observational
200
Kaohsiung City, Taichung, Taipei, Taoyuan
2024-10-22
Active, closed
AstraZeneca
Phase 3
25
Kaohsiung City, Taipei, Taoyuan
2024-10-15
Active, closed
AstraZeneca
Phase 3
768
Changhua, Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei
2024-10-04
Active, closed
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
NCT06450197Moderate to Severe Crohn's Disease
DrugAZD7798
AstraZeneca
Phase 2
120
New Taipei City, Taichung, Taipei, Taoyuan
2024-08-28
Active, closed
AstraZeneca
Phase 2
194
Changhua, New Taipei City, Taipei
2024-08-27
Recruiting
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
NCT06535607Sub-study 1 Cervical Cancer (Volrustomig Monotherapy), Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy), Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy), Sub-study 4 Esophageal Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)
DrugsVolrustomig·Adrucil·Paclitaxel·Cisplatin
AstraZeneca
Phase 2
257
Kaohsiung City, Taichung, Taipei
2024-08-22
Recruiting
AstraZeneca
Phase 3
620
Kaohsiung City, Taichung, Taipei, Taoyuan
2024-08-12
Recruiting
AstraZeneca
Phase 3
1,018
Changhua, Kaohsiung City, Lukang Township, Tainan, Taipei
2024-08-07
Recruiting
AstraZeneca
Phase 3
788
New Taipei City, Taichung, Tainan, Taipei, Taoyuan
2024-08-01
Recruiting
AstraZeneca
Phase 2
80
Kaohsiung City, Tainan, Taipei
2024-07-16
Active, closed
AstraZeneca
Phase 3
339
Kaohsiung City, Taichung, Taipei
2024-06-29
Recruiting
AstraZeneca
Phase 3
240
Kaohsiung City, New Taipei City, Taichung, Taipei, Taoyuan
2024-06-20
Recruiting
AstraZeneca
Phase 3
582
Taichung, Tainan, Taipei, Taoyuan
2024-04-29
Active, closed
AstraZeneca
Phase 2
76
Tainan, Taipei
2024-04-21
Recruiting
AstraZeneca
Phase 3
3,850
Changhua, Kaohsiung City, New Taipei City, Taichung, Taipei, Taoyuan, Yilan, Yung Kang City
2024-04-12
Recruiting
AstraZeneca
Phase 3
675
Changhua, Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan
2024-04-11
Active, closed
AstraZeneca
Phase 3
2,554
Kaohsiung City, New Taipei City, Taichung, Taipei, Taoyuan, Yung Kang City
2024-03-29
Active, closed
AstraZeneca
Phase 3
594
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2024-03-04
Recruiting
AstraZeneca
Phase 3
5,250
Changhua County, Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan, Taoyuan City, Yunlin
2024-02-21
Recruiting
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
NCT06137118B-cell Acute Lymphoblastic Leukemia (B-ALL)
DrugSurovatamig
AstraZeneca
Phase 1/2
255
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2023-12-29
Recruiting
Observational Study Protocol: LIVER-R
NCT06252753Hepatobiliary Cancers
AstraZeneca
Observational
4,000
Taichung, Kaohsiung City, Taipei, Taoyuan City
2023-12-20
Recruiting
AstraZeneca
Phase 3
1,145
Changhua, Kaohsiung City, Taichung, Taipei, Taoyuan
2023-12-14
Recruiting
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
NCT06219941Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer, Pancreatic Ductal Adenocarcinoma
DrugsL-leucovorin·Nanoliposomal Irinotecan·Onivyde·Sonesitatug Vedotin
AstraZeneca
Phase 2
226
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2023-12-13
Active, closed
AstraZeneca
Phase 3
760
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2023-12-04
Recruiting
AstraZeneca
Phase 3
625
Hsinchu, Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2023-11-23
Active, closed
AstraZeneca
Phase 3
1,898
Kaohsiung City, Taichung, Taoyuan, Yung Kang City
2023-11-21
Active, closed
AstraZeneca
Phase 3
1,902
Changhua, Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2023-11-14
Active, closed
AstraZeneca
Phase 3
863
Kaohsiung City, Taichung, Taipei
2023-11-09
Active, closed
AstraZeneca
Phase 3
1,835
Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan
2023-11-07
Active, closed
AstraZeneca
Phase 3
895
Kaohsiung City, New Taipei City, Tainan, Taipei, Taoyuan, Yunlin
2023-10-24
Active, closed
AstraZeneca
Phase 3
5,511
Hsinchu, Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Yongkang District
2023-10-05
Recruiting
AstraZeneca
Phase 3
800
Changhua, Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan
2023-09-22
Active, closed
AstraZeneca
Phase 2
60
Kaohsiung City, Taichung, Tainan, Taipei, Yunlin
2023-07-18
Recruiting
Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
NCT06005493Gastric Cancer, Gastro-esophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma, Esophageal Adenocarcinoma
DrugRilvegostomig
AstraZeneca
Phase 1/2
392
Kaohsiung City, Tainan, Taoyuan
2023-07-11
Recruiting
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
NCT05797168Ovarian Cancer, Lung Adenocarcinoma, Endometrial Cancer, Lung Squamous Cell Carcinoma
DrugsPalacaparib·Torvutatug samrotecan·Saruparib·Paraplatin
AstraZeneca
Phase 1/2
622
Taichung, Tainan, Taipei
2023-06-05
Active, closed
AstraZeneca
Phase 3
37
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2023-05-08
Active, closed
AstraZeneca
Phase 2
294
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2023-04-24
Active, closed
AstraZeneca
Phase 3
94
Kaohsiung City, Taoyuan
2023-04-05
Recruiting
AstraZeneca
Phase 3
4,300
Hsinchu, Kaohsiung City, Taichung, Tainan, Taipei
2023-03-31
Active, closed
AstraZeneca
Phase 2
188
Hualien City, Kaohsiung City, Taichung, Taipei
2023-03-06
Recruiting
AstraZeneca
Phase 2
163
Hsinchu, Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2023-01-16
Active, closed
AstraZeneca
Phase 3
1,350
Hsinchu, New Taipei City, Taichung, Tainan, Taipei, Taoyuan
2022-12-29
Active, closed
First in Human Study of AZD9592 in Solid Tumors
NCT05647122Advanced Solid Tumours, Carcinoma Non-small Cell Lung, Head and Neck Neoplasms, Colorectal Neoplasms
DrugsAZD9592·Osimertinib·Leucovorin·Adrucil
AstraZeneca
Phase 1
190
Taichung, Taipei, Taoyuan
2022-12-21
Recruiting
AstraZeneca
Phase 3
3,527
Kaohsiung City, Taichung, Taipei, Taoyuan, Taoyuan City
2022-12-13
Active, closed
AstraZeneca
Phase 3
1,174
Hsinchu, Taichung, Tainan, Taipei, Taoyuan, Yung Kang City
2022-11-28
Active, closed
AstraZeneca
Phase 3
594
Taichung, Tainan, Taipei, Taoyuan, Yunlin
2022-09-15
Recruiting
AstraZeneca
Phase 2
454
Liou Ying Township, Taipei, Taoyuan
2022-09-06
Active, closed
AstraZeneca
Phase 3
341
Chiayi City, Hsinchu, Kaohsiung City, Liuying, Taichung, Taipei
2022-08-03
Active, closed
AstraZeneca
Phase 3
644
Hsinchu, Taichung, Tainan, Taipei, Taoyuan
2022-05-16
By invitation
AstraZeneca
Phase 3
214
Taichung, Tainan, Taipei, Taoyuan
2022-04-19
Recruiting
AstraZeneca
Phase 2
630
Liuying, New Taipei City, Tainan, Taipei
2022-04-14
Active, closed
AstraZeneca
Phase 3
760
Taichung, Tainan, Taipei, Taoyuan
2022-03-28
Active, closed
AstraZeneca
Phase 3
1,035
Kaohsiung City, Taichung, Tainan, Taipei
2022-03-25
Active, closed
AstraZeneca
Phase 3
390
Taichung, Tainan, Taipei, Taoyuan
2022-02-21
Active, closed
AstraZeneca
Phase 3
791
Hsinchu, New Taipei City, Taichung, Tainan, Taipei, Taoyuan
2022-02-18
Active, closed
AstraZeneca
Phase 3
363
Kaohsiung City, New Taipei City, Taichung, Taipei
2022-02-15
Active, closed
AstraZeneca
Phase 3
1,051
Hsinchu, New Taipei City, Taichung, Taipei, Taoyuan City
2022-02-07
Active, closed
AstraZeneca
Phase 3
454
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2021-10-28
Active, closed
AstraZeneca
Phase 3
148
Kaohsiung City, Taichung, Tainan
2021-10-28
Active, closed
AstraZeneca
Phase 3
927
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2021-10-25
Recruiting
AstraZeneca
Phase 1/2
460
Taichung, Tainan, Taipei, Taoyuan
2021-10-18
Active, closed
AstraZeneca
Phase 3
732
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2021-10-18
Active, closed
AstraZeneca
Phase 1/2
212
Taichung, Tainan, Taipei
2021-09-14
Active, closed
AstraZeneca
Phase 3
712
Taichung, Tainan
2021-08-05
Active, closed
AstraZeneca
Phase 3
315
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2021-06-30
Active, closed
AstraZeneca
Phase 3
893
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2021-05-10
Active, closed
AstraZeneca
Phase 3
1,157
Taichung, Tainan, Taipei, Taoyuan
2021-04-26
Recruiting
AstraZeneca
Phase 1
304
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2021-03-09
Active, closed
A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma
NCT04594642B-cell Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma
DrugSurovatamig
AstraZeneca
Phase 1
226
Kaohsiung City, Kweishan, Tainan, Taipei
2021-03-02
Active, closed
AstraZeneca
Phase 1
155
Hsinchu, Taichung, Tainan, Taipei, Taoyuan
2021-02-02
Active, closed
AstraZeneca
Phase 3
1,371
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2021-01-28
Active, closed
AstraZeneca
Phase 1/2
245
Hualien City, Tainan, Taipei, Taoyuan City
2020-12-28
Active, closed
AstraZeneca
Phase 1
138
Kaohsiung City, Taichung, Taipei, Taoyuan
2020-12-17
Active, closed
AstraZeneca
Phase 3
358
Taichung, Tainan, Taipei
2020-12-16
Active, closed
AstraZeneca
Phase 3
957
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan City
2020-11-17
Active, closed
AstraZeneca
Phase 3
640
Changhua, Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2020-10-19
Active, closed
AstraZeneca
Phase 3
370
Changhua, Taichung, Tainan, Taipei
2020-10-02
Active, closed
AstraZeneca
Phase 2
30
Taichung, Taipei, Taoyuan City
2020-09-28
Active, closed
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
NCT04482309Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer, Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
DrugTrastuzumab deruxtecan
AstraZeneca
Phase 2
477
Taichung, Tainan, Taipei, Taoyuan
2020-08-18
Active, closed
AstraZeneca
Phase 3
185
Taipei
2020-08-04
Active, closed
AstraZeneca
Phase 3
866
Taichung, Tainan, Taipei, Taoyuan
2020-07-24
Active, closed
AstraZeneca
Phase 3
1,012
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan City
2020-07-13
Active, closed
AstraZeneca
Phase 2
452
Kaohsiung City, Tainan, Taipei, Taoyuan
2020-06-03
Active, closed
AstraZeneca
Phase 3
818
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2020-04-16
Active, closed
AstraZeneca
Phase 3
155
Chiayi City, Hualien City, Kaohsiung City, Taichung, Tainan, Taipei
2020-01-20
Active, closed
AstraZeneca
Phase 3
587
Changhua, Hualien City, Kaohsiung City, Taichung, Taipei
2019-07-02
Active, closed
AstraZeneca
Phase 3
923
Hsinchu, Hualien City, Kaohsiung City, Tainan, Taipei
2019-06-25
Active, closed
AstraZeneca
Phase 3
810
Chiayi City, Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2019-04-16
Active, closed
AstraZeneca
Phase 2
367
Hsinchu, Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan
2019-01-09
Active, closed
AstraZeneca
Phase 1
175
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2018-12-27
Active, closed
AstraZeneca
Phase 1/2
243
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2018-12-21
Active, closed
AstraZeneca
Phase 3
825
Changhua, Taichung, Tainan, Taipei
2018-12-06
Active, closed
AstraZeneca
Phase 3
724
Kaohsiung City, Liou Ying Township, Taichung, Tainan, Taipei, Taoyuan City
2018-11-30
Active, closed
AstraZeneca
Phase 3
407
Taichung, Tainan, Taipei, Taoyuan
2018-11-27
Active, closed
AstraZeneca
Phase 3
1,063
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan City
2018-11-16
Active, closed
AstraZeneca
Phase 3
1,246
Taichung, Tainan, Taipei, Taoyuan
2018-09-27
Active, closed
AstraZeneca
Phase 3
730
Hsinchu, Kaohsiung City, Keelung, Taichung, Tainan, Taipei, Taoyuan City, Yunlin
2018-09-27
Active, closed
AstraZeneca
Phase 3
216
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2018-07-19
Active, closed
AstraZeneca
Phase 2
154
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan City
2018-03-16
Active, closed
AstraZeneca
Phase 2
273
Changhua, Kaohsiung Hsien, Taichung, Taipei, Taoyuan
2018-03-07
Recruiting
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
NCT03549754Type 2 Diabetes, Hypertension, Chronic Kidney Disease, Heart Failure
AstraZeneca
Observational
35,000
Changhua, Kaohsiung City, Niaosong, Taichung, Tainan, Taipei, Taoyuan City
2018-02-17
Active, closed
AstraZeneca
Phase 3
1,324
Chiayi City, Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2017-10-11
Active, closed
AstraZeneca
Phase 3
1,186
Changhua, Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2017-06-01
Active, closed
AstraZeneca
Phase 3
987
Changhua, Kaohsiung City, Taichung, Tainan, Taipei
2017-03-27
Active, closed
AstraZeneca
Phase 3
669
Taichung, Taipei
2017-01-02
Active, closed
AstraZeneca
Phase 3
1,126
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan City
2015-11-02
Active, closed
AstraZeneca
Phase 3
682
Changhua, Putzu City, Taichung, Tainan, Taipei, Taoyuan
2015-10-21
Active, closed
AstraZeneca
Phase 3
1,118
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2015-07-21
Active, closed
AstraZeneca
Phase 1
344
Kaohsiung City, Tainan, Taipei
2014-08-05
Active, closed
AstraZeneca
Phase 3
1,837
Changhua, Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2014-04-22
Rows per page Showing 1–166 of 166
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Taiwanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-taiwan

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Taiwan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,860 studies in total at the last sync on 12 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 166 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Taiwan?

78 of the 166 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 87 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 166 studies
PhaseStudiesRecruitingShare
Phase 31124767.5%
Phase 2271316.3%
Phase 1/21297.2%
Phase 11046%
Observational553%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
AstraZeneca16678

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Non-Small Cell Lung Cancer (9) Breast Cancer (9) Gastric Cancer (7) Hepatocellular Carcinoma (6) Endometrial Cancer (5) Biliary Tract Cancer (5) Non-small Cell Lung Cancer (5) Ovarian Cancer (4) Type 2 Diabetes Mellitus (4) Asthma (3) Chronic Kidney Disease and Hypertension (3) Metastatic Castration-resistant Prostate Cancer (2) Locally Advanced or Metastatic Non-Small Cell Lung Cancer (2) Triple Negative Breast Neoplasms (2) ER-Positive HER2-Negative Breast Cancer (2)
→

Browse trials by site location

Taipei (158) Taichung (139) Tainan (117) Kaohsiung City (115) Taoyuan (102) New Taipei City (38) Changhua (33) Hsinchu (16) Taoyuan City (15) Hualien City (8) Yunlin (7) Chiayi City (5) Zhubei (4)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.